Clinical trials for T-cell non-Hodgkin lymphoma
5 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT05989204TmCD19-IL18 in CD19+ CancersUniversity of Pennsylvania · PI: Jakub Svoboda, MD
- ACTIVE NOT RECRUITINGPhase 1NCT05377827Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic MalignanciesWashington University School of Medicine · PI: Geoffrey Uy, M.D.
- RECRUITINGPHASE1, PHASE2NCT04440436Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) PatientsBeijing Immunochina Medical Science & Technology Co., Ltd. · PI: Yuqin Song, MD, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT03434769AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin LymphomaBenjamin Tomlinson · PI: Benjamin Tomlinson, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02690545Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLUNC Lineberger Comprehensive Cancer Center · PI: Anne Beaven, MD